Extract

This is a Phase III trial designed to demonstrate that casopitant when added to dexamethasone and ondansetron is more effective in the prevention of vomiting then dexamethasone and ondansetron alone, in patients who receive a cisplatin-based highly emetogenic chemotherapy.

Inclusion criteria

• Nausea ,Vomiting

Country

• Argentina
• Belgium
• Bulgaria
• Croatia
• Czech Republic
• Finland
• Greece
• Hungary
• India
• Ireland
• Italy
• Korea, Republic of
• Malaysia
• Pakistan
• Philippines
• Poland
• Romania
• Slovakia
• Spain
• Taiwan, Province of China
• Thailand
• Ukraine

Links

• nct
• ictrp